Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma.

Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma. Leuk Res. 2004 Jun; 28(6):595-604.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Aged, 80 and over
Female
Fibroblast Growth Factor 2
Hepatocyte Growth Factor
Hodgkin Disease
Humans
Lymphoma, Follicular
Lymphoma, Large B-Cell, Diffuse
Lymphoma, Non-Hodgkin
Male
Middle Aged
Neoplastic Cells, Circulating
Neovascularization, Pathologic
Predictive Value of Tests
Ribonuclease, Pancreatic
Survival Rate
Vascular Endothelial Growth Factor A

authors with profiles

HAGOP M KANTARJIAN
KIM-ANH DO